- Record: found
- Abstract: found
- Article: not found
Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.
Ann Gardulf
1 ,
Uwe Nicolay ,
Dipl Math ,
Oscar Asensio ,
Ewa Bernatowska ,
Andreas Böck ,
Beatriz T Costa-Carvalho ,
Carl Granert ,
Stefan Haag ,
Dolores Hernández ,
Peter Kiessling ,
Jan Kus ,
Nuria Matamoros ,
Tim Niehues ,
Sigune Schmidt ,
Ilka Schulze ,
Michael Borte
Oct 2004
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
A large number of children and adults with primary antibody deficiencies need lifelong IgG replacement therapy. It is mostly unknown what effect the choice of replacement therapy has on the patients' health-related quality of life (HRQOL) and treatment satisfaction (TS).